Ann Lab Med.  2014 Jan;34(1):68-70. 10.3343/alm.2014.34.1.68.

A Case of Therapy-Related Acute Myeloid Leukemia With a Normal Karyotype After Sustained Molecular Complete Remission of Acute Promyelocytic Leukemia

Affiliations
  • 1Department of Laboratory Medicine, University of Ulsan College of Medicine and Asan Medical Center, Seoul, Korea. hschi@amc.seoul.kr
  • 2Department of Hematology, University of Ulsan College of Medicine and Asan Medical Center, Seoul, Korea.

Abstract

No abstract available.


MeSH Terms

Antineoplastic Agents/*adverse effects/*therapeutic use
Bone Marrow Cells/metabolism
Humans
Karyotyping
Leukemia, Myeloid, Acute/*chemically induced/*diagnosis/genetics
Leukemia, Promyelocytic, Acute/*drug therapy
Male
Middle Aged
Oncogene Proteins, Fusion/genetics
Remission Induction
Tretinoin/therapeutic use
Antineoplastic Agents
Oncogene Proteins, Fusion
Tretinoin

Reference

1. Jubashi T, Nagai K, Miyazaki Y, Nakamura H, Matsuo T, Kuriyama K, et al. A unique case of t(15;17) acute promyelocytic leukaemia (M3) developing into acute myeloblastic leukemia (M1) with t(7;21) at relapse. Br J Haematol. 1993; 83:665–668. PMID: 8518183.
2. Hatzis T, Standen GR, Howell RT, Savill C, Wagstaff M, Scott GL. Acute promyelocytic leukemia (M3): relapse with acute myeloblastic leukaemia (M2) and dic(5;17)(q11;p11). Am J Hematol. 1995; 48:40–44. PMID: 7832190.
3. Sawada H, Morimoto H, Wake A, Yamasaki Y, Izumi Y. Therapy-related acute myeloid leukemia with t(10;11)(q23;p15) following successful chemotherapy for acute promyelocytic leukemia with t(15;17)(q22;q21). Int J Hematol. 1999; 69:270–271. PMID: 10407587.
4. Zompi S, Legrand O, Bouscary D, Blanc CM, Picard F, Casadevall N, et al. Therapy-related acute myeloid leukaemia after successful therapy for acute promyelocytic leukaemia with t(15;17): a report of two cases and a review of the literature. Br J Haematol. 2000; 110:610–613. PMID: 10997972.
Article
5. Latagliata R, Petti MC, Fenu S, Mancini M, Spiriti MA, Breccia M, et al. Therapy-related myelodysplastic syndrome-acute myelogenous leukemia in patients treated for acute promyelocytic leukemia: an emerging problem. Blood. 2002; 99:822–824. PMID: 11806982.
Article
6. Athanasiadou A, Saloum R, Zorbas I, Tsompanakou A, Batsis I, Fassas A, et al. Therapy-related myelodysplastic syndrome with monosomy 5 and 7 following successful therapy for acute promyelocytic leukemia with anthracyclines. Leuk Lymphoma. 2002; 43:2409–2411. PMID: 12613533.
Article
7. Zompi S, Viguié F. Therapy-related acute myeloid leukemia and myelodysplasia after successful treatment of acute promyelocytic leukemia. Leuk Lymphoma. 2002; 43:275–280. PMID: 11999558.
Article
8. Lee GY, Christina S, Tien SL, Ghafar AB, Hwang W, Lim LC, et al. Acute promyelocytic leukemia with PML-RARA fusion on i(17q) and therapy-related acute myeloid leukemia. Cancer Genet Cytogenet. 2005; 159:129–136. PMID: 15899384.
Article
9. Park TS, Choi JR, Yoon SH, Song J, Kim J, Kim SJ, et al. Acute promyelocytic leukemia relapsing as secondary acute myelogenous leukemia with translocation t(3;21)(q26;q22) and RUNX1-MDS1-EVI1 fusion transcript. Cancer Genet Cytogenet. 2008; 187:61–73. PMID: 19027486.
Article
10. Batzios C, Hayes LA, He SZ, Quach H, McQuilten ZK, Wall M, et al. Secondary clonal cytogenetic abnormalities following successful treatment of acute promeylocytic leukemia. Am J Hematol. 2009; 84:715–719. PMID: 19806661.
11. Betancourt-García RD, Castro J, Fernández AC, López-Enríquez A, Fradera J, Pacheco E. Acquired acute myelogenous leukemia after therapy for acute promyelocytic leukemia with t(15;17): a case report and review of the literature. P R Health Sci J. 2009; 28:146–150. PMID: 19530558.
12. Montesinos P, González JD, González J, Rayón C, de Lisa E, Amigo ML, et al. Therapy-related myeloid neoplasms in patients with acute promyelocytic leukemia treated with all-trans-retinoic Acid and anthracycline-based chemotherapy. J Clin Oncol. 2010; 28:3872–3879. PMID: 20625122.
Article
13. Ojeda-Uribe M, Schneider A, Luquet I, Berceanu A, Cornillet-Lefebvre P, Jeandidier E, et al. Therapy-related acute myeloid leukemia (t-AML) with poor-risk cytogenetics in two patients with persistent molecular complete remission of acute promyelocytic leukemia. Eur J Haematol. 2012; 89:267–272. PMID: 22591288.
Article
14. Garcia-Manero G, Kantarjian HM, Kornblau S, Estey E. Therapy-related myelodysplastic syndrome or acute myelogenous leukemia in patients with acute promyelocytic leukemia (APL). Leukemia. 2002; 16:1888. PMID: 12200720.
Article
Full Text Links
  • ALM
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr